Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 20, 2025

XRP’s $500M Ripple Funding at $40B Valuation: Why Price Isn’t Moving

View original at finance.yahoo.com
XRP’s $500M Ripple Funding at $40B Valuation: Why Price Isn’t Moving DUSAN ZIDAR / Shutterstock.com Quick Read Ripple (XRP) raised $500M at a $40B valuation but the token price stayed flat for six months despite institutional backing…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Bearish case: XRP could slide toward $1.50–$2 or even $1.20 if ETF flows cool, macro risks intensify, and liquidity thins

    80% confidence
  • Ripple is expanding payment corridors and strengthening regulatory position with major institutional backing

    80% confidence
  • Enterprise adoption moves slowly and ODL corridors and RLUSD integrations don't instantly translate into higher token demand

    80% confidence
  • ODL corridors help institutions move money quickly but don't require large volumes of XRP to sit on balance sheets, with token often moving only for seconds during settlement

    80% confidence
  • Base case: XRP will spend 2026 floating between $2 and $3.50, hovering around $2.50–$3 by year-end

    80% confidence
  • Franklin Templeton's reputation and advisor network bring XRP into conversations it couldn't reach before, introducing slow, steady inflows from pension desks, RIAs, and conservative allocators

    80% confidence
  • If Ripple captures meaningful share of high-friction cross-border flows, XRP settlement volumes could grow several times over current levels

    80% confidence
  • Bullish case: XRP could recapture $3 zone and jump beyond $3.25 toward $5 or more by mid-2026 if institutional flows stay steady and payment rails gain traction

    80% confidence
  • Traders are focused on liquidity, whale movements, and actual settlement growth rather than big announcements

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
XRP’s $500M Ripple Funding at $40B Valuation: Why Price Isn’t Moving — Source | Via News | Via News